Prescrire IN ENGLISH - HOME

Register online | Log in | My Prescrire

Issue contents

About Prescrire

english.prescrire.org

Welcome to the Prescrire in English website

Reliable, rigorously independent information on treatments and healthcare strategies,
to enable fully informed decision-making. Prescrire is financed by its subscribers.
No grants, no advertising. No shareholders, no sponsors.

Prescrire's other websites

Prescrire.org Les Formations - APP Prescrire Campus Éviter l'Évitable

In Prescrire's Spotlight

Erenumab (Aimovig°) for the prevention of migraine attacks: decrease in the frequency of attacks in some patients, but uncertainty over cardiovascular effects

FEATURED REVIEW Erenumab (Aimovig°) is a monoclonal antibody that has been authorised in the European Union for the prevention of migraine attacks in patients who experience attacks on more than 4 days a month. Prescrire's editorial staff have weighed the available evidence to bring you an unbiased assessment of the drug's harm-benefit balance.
Full review (5 pages) available for download by subscribers.

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

In the September edition of Prescrire International: sartan medicines contaminated by impurities which are probable carcinogens

FREE DOWNLOAD The exposure of patients all around the world and over a period of several years to impurities which are known to be carcinogenic, and which were present in commonly used medicines, shows that the systems intended to guarantee pharmaceutical quality need to be improved.

Full text available for free download.

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

Carpal tunnel syndrome: sometimes drug-related

Carpal tunnel syndrome is sometimes caused by certain drugs, and disappears when the medication is stopped.

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

New drugs: investing in more informative clinical trials

More informative clinical trials are more expensive, but that is the price of better care.

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

Fluoroquinolones: use should be restricted due to severe adverse effects

Given the many and sometimes severe adverse effects of fluoroquinolone antibiotics, they should only be used for limited purposes.

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

Electronic product information: EMA and competent authorities must guarantee public access to quality information, and uphold the ban on direct-to-consumer advertising

ADVANCING HEALTHCARE POLICY In its response to the EMA consultation on key principles for electronic product information (ePI) for human medicines in the EU, Prescrire underscores the responsibility of EMA and other competent authorities to guarantee the quality of the dissemination of ePI, to avoid any deregulation and to uphold the EU’s ban on direct-to-consumer advertising for medicines. Any ePI should always be considered as option in addition to the printed version of the patient leaflet provided within the product packaging.

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

Enjoy these features, and more, in our upcoming issues

COMING SOON Tisagenlecleucel in acute lymphoblastic leukaemia in children and young adults • Drug-induced cytokine release syndrome • NSAIDs at the start of pregnancy: early miscarriages • Diabetes and primary prevention of cardiovascular disease • Paracetamol: patients are not sufficiently aware of the harms • Trials funded by drug companies: publication or publicity?... > Subscribe now

1 September 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

Subscribe today for full access to top-quality content from Prescrire International

Subscribe now Enjoy access to subscriber-only content available on our website, including every article published in Prescrire International since 1992. Prices for a one-year subscription start at 150 euros (less for students and residents of lower-income countries).

1 December 2018

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

"Top Texts of 2019", new from the editors of Prescrire International

NEW: FREE SPECIAL EDITION Check out this brand new sampling of texts selected by our editors to introduce you to Prescrire International, a wholly independent monthly journal, written by and for healthcare professionals

28 August 2019

¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯¯

Receive the free, monthly "Independent Drug & Healthcare Newsletter"

Click here to sign up for the free Newsletter from the editors of the non-profit journal Prescrire International, with highlights of the contents of the latest issue.

1 September 2018

Contents of Issue 207 September 2019

Sign up here

No grants, no advertising

Subscribe now to Prescrire International

Free Special Edition

Advancing healthcare policy